1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapymicrophthalmia, syndromic 9Active, not recruitingPhase 22025-12-05NCT07176702